Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for chronic osteoarthritis pain
2015-001669-16Phase 3Terminated
- Sponsor
- Erasmus MC
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of duloxetine in osteoarthritis (OA) (2 arms), sponsored by Erasmus MC. Primary endpoint: Pain at 3 months. Started May 2015; status: terminated.
02
Drugs
duloxetine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2015-001669-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001669-16.